by Stem Cell Network | Jun 18, 2010
We’re a the ISSCR meeting in San Francisco inviting folks to stop by the Stem Cell Network booth (number 509), sit on our comfy couch and talk about what they’ve enjoyed the most at the 2010 ISSCR annual meeting. Featured here are Bernard Thébaud of the...
by Chris Kamel | Jun 14, 2010
Simple diagram that shows the development of different blood cells from hematopoietic stem cell to mature cells. From Wikipedia. All blood cells arise from the common hematopoietic stem cell and are classified into two lineages: lymphoid cells (B-, T- and Natural...
by Chris Kamel | Jun 11, 2010
When using stem cells for regenerative therapies, there are a few approaches that can be taken. Donor cells have issues with matching and immune rejection. Autologous stem cells transplants skirt rejection issues, but both strategies still face challenges associated...
by Katie Moisse | Jun 4, 2010
The UK-based Motor Neurone Disease Association has recently funded a £800,000 ($1.2 million) program to study motor neurons derived from the skin cells of amyotrophic lateral sclerosis (ALS) patients with rare, disease-causing mutations in the gene TARBP. Although the...
by Allison Van Winkle | May 27, 2010
The potential gains from stem cell research are unlimited; stem cells could be used to replace degenerated cells and tissue in the human body. However, the large scale implementation of stem cell therapy to a clinical setting will require the establishment of a...
by Chris Kamel | May 20, 2010
One hurdle facing the use of lab-grown stem cells for therapeutic or experimental purposes is the accumulation of genetic abnormalities over time. The nature of these changes varies, but some may affect therapeutic usefulness and many mirror changes seen in...
Comments